Association studies were also done between the percentage of CD4+ Treg subsets and other clinical and pathological characteristics, including T grouping, histological grade, muscular invasion, lymphovascular invasion, perineural invasion, and carcinoma in situ. The gene discussed is CD4; the disease is in situ carcinoma.